Patent · US Active

Sgp130/Fc dimers

US9573989B2 · kind B2 · utility

18Cited by
11References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2015
Grant dateFeb 21, 2017
Priority date
Expiry dateApr 17, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described are polypeptide dimers comprising two soluble gp130 molecules wherein each of said molecules is fused to an Fc domain of an IgG1 protein and wherein the hinge region of the Fc domain is modified resulting in advantageous properties of the dimer. In a particularly preferred embodiment, the hinge region comprises the amino acid sequence motif Ala234-Glu235-Gly236-Ala237. Moreover, a pharmaceutical composition containing said dimer and various medical uses are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.